- Home
- IVDA vs MYNZ Comparison
IVDA vs MYNZ Comparison
Compare IVDA & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IVDA | MYNZ |
|---|---|---|
| Founded | 2003 | 2021 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5M | 5.8M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | IVDA | MYNZ |
|---|---|---|
| Price | $1.04 | $1.06 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | ★ 9.2M | 305.7K |
| Earning Date | 11-14-2025 | 12-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $6,395,926.00 | $659,935.00 |
| Revenue This Year | $340.48 | N/A |
| Revenue Next Year | N/A | $5.03 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 20.56 | N/A |
| 52 Week Low | $0.61 | $0.92 |
| 52 Week High | $8.05 | $8.20 |
Technical Indicators
Market Signals| Indicator | IVDA | MYNZ |
|---|---|---|
| Relative Strength Index (RSI) | 47.59 | 37.14 |
| Support Level | $1.11 | $1.04 |
| Resistance Level | $1.37 | $1.15 |
| Average True Range (ATR) | 0.16 | 0.09 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 33.15 | 39.29 |
Price Performance
Historical ComparisonAbout IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.